#Cannabis News: Cannabis Suisse (OTC: $CSUI) Launches Pre-Rolled Cannabis Joints Based on the V1 Cannabis Strain; @SuisseCorp
#Cannabis News: Cannabis
Suisse (OTC: $CSUI) Launches Pre-Rolled Cannabis Joints Based on the V1
Cannabis Strain; @SuisseCorp
Switzerland - May 11, 2020 (Investorideas.com Newswire) For the purpose of
standing out, Cannabis Suisse Corp. (OTC: CSUI) has announced a new retail product in the
variety of the Company's offerings. They range from helping consumers grow
their own Cannabis plants to a revolutionary pure base CBD vape liquid. During
the global crisis the Company is not ceasing to create and deliver innovative
the cannabis industry has developed, the brands on the market have been working
extensively on improving the production quantity and the quality of pre-rolled
joints. They have become so popular among users of recreational cannabis due to
their small size and compactness.
a rather easy-to-use product that delivers an enjoyable and unique experience
anytime people use it.
consistency of the joints is simply royal which is no surprise due to Cannabis
Suisse Corp. getting permission to use RAW brand on their pre-rolled boxes. RAW
is known for their best of the best rolling papers. They come unbleached,
contain neither chalk, nor dyes, nor flammable additives. These papers just
immerse smokers into the experience of using the finest strains of V1 cannabis.
Wrapped in unrefined natural paper, the joints give customers a unique smoking
experience with a gourmet taste.
V1 is special for its ability to relax users without sedation and to relieve
them without intoxication. It is not new, however, appears to be the best
strain on the market currently. The V1 strain is an immensely powerful CBD
plant and is guaranteed to contain not less than 20% CBD along with no more
than 0.85% THC. It is delicious to smoke having a natural hint of lemon and
lime flavors and an enjoyable fresh aftertaste.
V1 strains are derived from recreational strains and are one of the
best-selling products on the market. Over the last few years, the V1 has surely
become one of the most exciting CBD strains containing around 90% Sativa and
10% Indica. The V1 plant is known to have low yield however it is widely used
for therapeutic purposes. People who tried consuming it in different ways
report having a feeling of peace and relaxation. It is easy to recognize by
hard compact flowerheads. Apart from the crystal appearance, the V1 also has a
strong specific scent.
will be the main strain for ALPINE CANNABIS CBD tobacco production.
users from California, Colorado, Arizona, Oregon, and Washington spent around
$36 million in pre-rolled joints only in May of 2019 according to the report
introduced by BDS Analytics. (https://bdsa.com/wp-content/uploads/2019/07/CPI-Template-May.pdf) Apart from that,
at the end of 2019, the Swiss government finally removed the 25% tobacco tax
which was a significant event for the country. In five years from now, Europe
is expected to become the largest legal cannabis market in the world. In 2019,
the industry there has grown more than in the last six years together.
always, CSUI's pre-rolled CBD joints are wrapped in premium quality paper from
RAW. They will be made only of quality fresh buds (no leaves, of course)
cultivated with non-pesticide fertilizers and biological control agents. The
new product line of handmade pre-rolled CBD joints will have no additives. They
are free from pesticides, fungicides, heavy metals or nicotine. Natural hemp is
always manually harvested and selected with care. No post-harvest wash
processing of the cannabis applies. The final product contains all the natural
terroir it is supposed to have. This is the Cannabis Suisse finest
ready-to-smoke weed product ever cultivated using proprietary growing methods
in fully contained facilities in Zurich, Switzerland.
Suisse is the first company in Switzerland to offer this uniquely blended
fusion of organic cones with optimally boosted CBD content. The THC level has
been naturally kept under 1%. CBD flower pre-rolled joints are an all-natural
alternative to CBD oil products. They offer pain-relieving, calming, and
cannabis consumer knows how difficult it is to choose a pre-rolled joint. There
are lots of doubts whether a package has really as much cannabis flower as the
manufacturer indicated, how joints will be wrapped and glued, how they will
smolder. Alpine Cannabis buyers will never encounter such problems. The company
maintains its work at a high-quality standard. The trademark gives consumers
100% confidence they will get premium quality goods. The quality of the
pre-rolled joints is not going to be different from the quality of cannabis
buds in bags where consumers can make sure what they are buying.
upon trying and realizing the convenience of the joints, consumers will return
for them over and over again.
step of the creation process is taken by masters. The Company is happy to
present the highest quality and best priced CBD flower pre-rolled joints for
the Swiss retail market. The V1 strain is currently growing and the first
retail supplies of this product are expected to be ready for selected vendors
in July 2020.
has forward-looking plans to expand outside Switzerland developing customized
products. Some European countries like Germany, Denmark, Malta, Greece, and
Italy discussed the possibility of creating a completely regulated cannabis
market by 2028.
Luxembourg intends to introduce a regulated market for adult use of cannabis by
on all of the above advantages of the Company's product, the situation in the
European market and forthcoming amendments to the legislation, the Company's
decision to launch a new product line is more than an appropriate and timely
one. An investment in this production will pay off for the company in the
nearest future, increase the income, and make the brand recognizable. In our
forecasts, to get a minimum of 400,000 CHF 12 months after the start of sales.
CSUI's pre-rolled joints will become another business card of the Company's
trademark. The product will occupy this niche in the market, crowding out other
ABOUT CANNABIS SUISSE CORP.
Cannabis Suisse Corp. is a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online
shops, under the retail brand Alpine Cannabis.
press release may contain certain forward-looking statements and information,
as defined within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe
Harbor created by those sections. This material contains statements about
expected future events and/or financial results that are forward-looking in
nature and subject to risks and uncertainties. Such forward-looking statements
by definition involve risks, uncertainties and other factors, which may cause
the actual results, performance or achievements of Cannabis Suisse Corp. to be
materially different from the statements made herein.
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions.